Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -450.38% is 680% below its 5-year average of -57.72%, near the low end of its 5-year range (-627.66%–58.02%).
As of the fiscal period ended Tuesday, March 31, 2026. 161.37% below its 12-month average of -172.32%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
-450.38%
NET PROFIT MARGIN AVG TTM
-172.32%
NET PROFIT MARGIN AVG 3Y
-51.52%
NET PROFIT MARGIN AVG 5Y
-7.05%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-161.37%
CURRENT VS 3Y AVG
-774.13%
CURRENT VS 5Y AVG
-6284.23%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
10.44%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-4413.99%
vs the sector median at left
BioNTech SE
Market Cap
$22.59B
Net Profit Margin
-450.38%
TTM Avg
-172.32%
3Y Avg
-51.52%
5Y Avg
-7.05%
Market Cap
$22.43B
Net Profit Margin
40.61%
TTM Avg
41.73%
3Y Avg
40.84%
5Y Avg
37.71%
Market Cap
$23.10B
Net Profit Margin
16.98%
TTM Avg
16.55%
3Y Avg
18.38%
5Y Avg
18.84%
Market Cap
$23.51B
Net Profit Margin
26.71%
TTM Avg
12.90%
3Y Avg
13.00%
5Y Avg
12.11%
Market Cap
$21.45B
Net Profit Margin
-143.55%
TTM Avg
-128.24%
3Y Avg
-70.25%
5Y Avg
-50.87%
Market Cap
$24.34B
Net Profit Margin
6.66%
TTM Avg
6.01%
3Y Avg
6.56%
5Y Avg
9.24%
Market Cap
$24.42B
Net Profit Margin
11.91%
TTM Avg
20.93%
3Y Avg
21.85%
5Y Avg
22.39%
Market Cap
$20.08B
Net Profit Margin
-2.04%
TTM Avg
-14.44%
3Y Avg
-3.94%
5Y Avg
-4.74%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioNTech SE (BNTX) | $22.59B | -450.38% | -172.32% | -51.52% | -7.05% |
| United Therapeutics Corporation (UTHR)vs › | $22.43B | 40.61% | 41.73% | 40.84% | 37.71% |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.10B | 16.98% | 16.55% | 18.38% | 18.84% |
| Incyte Corporation (INCY)vs › | $23.51B | 26.71% | 12.90% | 13.00% | 12.11% |
| Moderna, Inc. (MRNA)vs › | $21.45B | -143.55% | -128.24% | -70.25% | -50.87% |
| STERIS plc (STE)vs › | $20.86B | 13.18% | 12.25% | 8.55% | 8.79% |
| Labcorp Holdings Inc. (LH)vs › | $24.34B | 6.66% | 6.01% | 6.56% | 9.24% |
| Waters Corporation (WAT)vs › | $24.42B | 11.91% | 20.93% | 21.85% | 22.39% |
| Viatris Inc. (VTRS)vs › | $20.08B | -2.04% | -14.44% | -3.94% | -4.74% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.15B | 12.02% | 8.91% | 9.15% | 11.71% |
Operating Margin
-22.6%
Net Profit Margin
-450.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | -450.38% |
| 2025-12-31 | -33.61% |
| 2025-09-30 | -1.89% |
| 2025-06-30 | -148.24% |
| 2025-03-31 | -227.46% |
| 2024-12-31 | 21.81% |
| 2024-09-30 | 15.91% |
| 2024-06-30 | -627.66% |
| 2024-03-31 | -167.96% |
| 2023-12-31 | 30.96% |
| 2023-09-30 | 17.94% |
| 2023-06-30 | -113.54% |
| 2023-03-31 | 39.33% |
| 2022-12-31 | 53.26% |
| 2022-09-30 | 51.57% |
| 2022-06-30 | 52.31% |
| 2022-03-31 | 58.02% |
| 2021-12-31 | 57.23% |
| 2021-09-30 | 52.75% |
| 2021-06-30 | 52.50% |
| 2021-03-31 | 55.07% |
| 2020-12-31 | 106.22% |
| 2020-09-30 | -311.11% |
| 2020-06-30 | -211.75% |
| 2020-03-31 | -192.78% |
| 2019-12-31 | -208.03% |
| 2019-09-30 | -105.03% |
| 2019-06-30 | -194.24% |
| 2019-03-31 | -155.41% |
| 2018-12-31 | -2.12% |
| 2018-09-30 | -114.88% |
| 2018-06-30 | -53.54% |
| 2018-03-31 | -53.54% |
